Abstract-Background: Multifocal motor neuropathy (MMN) is often misdiagnosed as motor neuron disease, especially when overt evidence of conduction block (CB) is lacking. Activity-dependent CB (ADCB), defined as transient CB induced by brief exercise, has been recently found in MMN but not in ALS. Methods: To test the diagnostic utility of ADCB for differentiating MMN from ALS, the authors recorded the compound muscle action potentials (CMAPs) from small hand muscles by magnetically stimulating nerve roots before and after 1 minute of maximal voluntary contraction (magnetic fatigue test). They examined nine patients with MMN with unequivocal clinical responses to IV immunoglobulins (IVIgs), yet lacked CB according to the conventional criteria. Results: Six MMN patients had postexercise CB/temporal dispersion maximum in the immediate postexercise period. ADCB in an MMN patient improved after IVIg. Further analysis revealed that prolongation of the duration from the onset to the positive peak of the CMAP was the most sensitive indicator for MMN, presumably because the phase cancellation obscures the abnormalities of the other parameters. Conclusion: The magnetic fatigue test is useful in detecting mild conduction block presumably located in a proximal nerve segment in patients with multifocal motor neuropathy who do not fulfill its conventional electrodiagnostic criteria.
Multifocal motor neuropathy (MMN) is demyelinating and characterized by predominant involvement of motor nerves, presenting with slowly progressive muscle atrophy and weakness. [1] [2] [3] [4] [5] [6] MMN is treatable with IV immunoglobulin (IVIg) infusion, and this makes differential diagnosis from ALS and other lower motor neuron (LMN) syndromes clinically important. 1, [7] [8] [9] An elevated antibody titer against GM1 suggests an immunologic pathogenesis, but a normal antibody titer does not exclude MMN due to its low sensitivity. Another important diagnostic feature is demonstration of conduction block (CB) in multiple peripheral nerves, involving solely motor axons, with sensory conduction spared across the segment of the motor CB. 3, 6 ,10 CB may not, however, be demonstrable in MMN, where the lesion is located at a proximal nerve segment (e.g., plexus, nerve root) 11 or the neuropathy is purely axonal. 12, 13 Given the fact that patients with presumably demyelinative MMN with no overt CB, who are otherwise indistinguishable from those with CB, may respond as well to IVIg as those with CB; the absence of overt CB does not preclude the diagnosis of MMN. [14] [15] [16] Because ALS and other forms of LMN syndrome are not always clinically distinguishable, MMN may be underdiagnosed in those without definitive evidence of CB or elevation of anti-GM1 antibody. Thus, a diagnostic test that can effectively distinguish between ALS/LMN syndrome and MMN without overt CB is needed, lest one misses the chance of therapy.
Patients with MMN develop transient aggravation of weakness by sustained muscular contraction (fatigue) with no abnormality in neuromuscular junction. 17 This phenomenon is associated with transient or activity-dependent CB (ADCB), the pathophysiology of which has been ascribed to Na ϩ -K ϩ pumpinduced axonal hyperpolarization. [17] [18] [19] [20] The purpose of this study was to elucidate whether 1) ADCB by magnetic root stimulation occurs in MMN in those in whom overt CB is lacking on routine electrodiagnostic tests and 2) ADCB can differentiate MMN from ALS, especially with predominantly lower motor neuron involvement. We selected patients with ALS for comparison because the sporadic forms of LMN is rather heterogeneous with their pathophysiology still largely unknown.
Methods. Selection criteria. Recordings were made from two groups of the patients: those with MMN and those with ALS. The inclusion criteria for the MMN patients in the present study were 1) progressive muscle atrophy and weakness in the distribution of a few peripheral nerves or roots without sensory involvement; 2) lack of upper motor neuron signs, pathologic reflexes, or bulbar symptoms/signs; 3) the lack of radiologic abnormality in the cervical spine region by MRI scan; 4) lack of CB by published electrodiagnostic criteria 21 ; and 5) most importantly, the presence of clinical improvement of the affected limb with IVIg therapy (2 g/kg divided over five consecutive days), defined as the improvement of the pre-vs posttherapeutic modified Medical Research Council (MRC) score (scale of 1 to 5 including 4-and 4ϩ grades) Ն2 in at least two of the affected muscles. The mean duration of our clinical follow-up in MMN was 40.3 months (range 18 to 102), and all the patients remained ambulatory. The mean number of the IVIg treatments was 9.4 (range 4 to 16) with reproducible posttherapeutic improvement. Unlike typical patients with chronic inflammatory demyelinating polyneuropathy, our MMN patients had normal CSF protein levels (normal range 15 to 40 mg/dL). Inclusion criteria for the ALS group were meeting the clinically definite or probable revised El Escorial ALS criteria. 22 However, at the time of the magnetic fatigue test, the diagnosis of ALS was not made because of the predominant lower motor neuron involvement. They later developed upper motor neuron signs, thus meeting El Escorial ALS criteria. Therefore, the clinical distinction between MMN and ALS in the present patients was not straightforward. All the patients gave informed consent to participate in the study. This study was performed in accordance with the principles embodied in the Declaration of Helsinki and was approved by the Institutional Review Board in Tokushima University.
Conventional nerve conduction studies and repetitive stimulation. Nerve conduction studies were performed with percutaneous stimulating and recording electrodes using Viking IV (Nicolet Biomedical, Madison, WI). The distal motor latency (DL), motor nerve conduction velocity (CV), and compound muscle action potential (CMAP) were elicited with distal and proximal stimulation of the median nerve (at the wrist with a 7-cm stimulating recording distance and at the elbow) and of the ulnar nerve (at the wrist with 7-cm stimulating recording distance and on the forearm below elbow). Sixteen to 32 stimulations at 1 Hz were applied to elicit at least 10 F waves and the minimal latency was recorded. Additional sites of stimulation (the axilla and Erb's point for the median nerve and above the elbow, the axilla, and Erb's point for the ulnar nerve) did not show either CB or temporal dispersion in any of the tested subjects. Also, tibial and peroneal nerves were stimulated according to a standard technique, 23 and all the subjects were within normal limits.
To exclude a neuromuscular transmission defect as a cause of fatigue, all the patients with MMN and ALS were tested by 3-Hz repetitive stimulation of the affected nerve stimulated at the wrist using a standard technique and demonstrated normal results. 24 Clinical features and nerve conduction study. The features of the clinical and nerve conduction studies of the patients are shown in table 1. All the patients with MMN and ALS had weakness (modified MRC score in the 3 to 4ϩ range) of the small hand muscles on the side on which the neurophysiologic tests were performed. Between the MMN and ALS groups, the mean ages and the routine electrodiagnostic features were similar, except for longer DL of the ulnar motor study in MMN, which is supportive of demyelination. However, its diagnostic value was limited because of the significant overlap of the values between the two groups. No overt CB was identified in the MMN group. 6 The MMN patients were predominantly men (p Ͻ 0.05 vs ALS), consistent with previous studies. 25, 26 In the MMN group, the antiganglioside titer was positive in only one of the eight patients (positive for GM1 IgM and GA1 IgM classes), similar to the previous report. 12 Hence, the absence of anti-ganglioside antibody does not rule out the possibility of MMN.
Magnetic root stimulation and magnetic fatigue test. Transcutaneous magnetic stimulation (TMS) of the cervical and upper thoracic roots was performed with a magnetic stimulator (Magstim Model 200, Magstim, UK) and a commercially available circular coil with an outer diameter of 12 cm. The subject was seated in a comfortable chair with the head slightly bent forward and the forearms fixed on the armrest. The center of the magnetic coil was initially placed over the C7 spinous process with slight vertical adjustment afterward to obtain the highest CMAP amplitude. Clockwise coil current was used for recordings from the right side of the limb and vice versa. The CMAP recordings were made over the abductor pollicis brevis (APB). The first dorsal interosseus (FDI) was used in patients with severe APB atrophy (one patient each in MMN and ALS groups). The recording electrode and reference electrode were placed over the motor point and tendon of the tested muscle with the use of self-adhesive, 3 ϫ 2-cm Ag/AgCl electrodes (Nicolet Biomedical). A self-adhesive 5 ϫ 4 cm Ag/AgCl ground electrode (Nicolet Biomedical) was placed between the stimulator and the active recording electrode. In normal controls, no difference in the CMAP parameters was found between recordings over APB and FDI by TMS. The isometric maximal voluntary contraction (MVC) of the chosen muscle was performed against constant resistance for 60 seconds, and the subject was asked to fully relax after the MVC. Positioning of the coil and the posture of the subjects were kept stable during the serial recordings.
Baseline recordings were obtained by increasing the stimulus intensity in about 10% increments to 100% of the maximal output for reproducible supramaximal CMAP recordings (Neuropack MEB2200, Nihon Koden, Tokyo, Japan) with its recording parameters of sweep speed of 5 to 10 msec per division, sensitivity of 0.5 to 10 mV per division, and band pass of 1 Hz to 5 kHz. Two to three serial baseline recordings, 5 seconds apart, were performed for reproducibility, and further recordings were made immediately after finishing MVC, and every 1 minute thereafter up to 5 minutes. Because the serial recordings were reproducible, the averaged data were used for further analysis to allow better demonstration of the peaks of the waveforms. DL represents the onset of the CMAP after stimulation. The amplitude of the CMAP was measured from baseline to negative peak of the waveform. The area of the negative phase of the CMAP (from its onset to the returning to the baseline) was obtained. The duration of the CMAP was measured as illustrated in figure 1A . The skin temperature of the dorsum of the hand was measured and maintained between 32°C and 34°C during the experiment.
The titers for IgM and IgG anti-ganglioside antibodies were obtained for GM1, GM2, GM3, GD1a, GD1b, GD3, GT1b, GQ1b, GA1, Gal-C, and GalNAc-GD1a by Dr. S. Kusunoki (Kinki University and Tokyo University, Japan). 13, 27, 28 To determine normative values for magnetic stimulation, control data were obtained from 12 healthy individuals (ages 21 to 50 years, six men and six women) without any neurologic symptoms or signs. All subjects gave informed consent.
Analysis of variance with post hoc analysis (Scheffé) (for comparison of MMN, ALS, and control groups), Mann-Whitney U test (for comparison of MMN and ALS groups), and Fisher's exact test (for comparison of proportion) were used for data analysis (SPSS 11.0, Chicago, IL). A p value Ͻ0.05 was considered significant. Figure 2 depicts the represen- 17 More specifically, the transient postexercise prolongation of the durations of the phases (figure 1) did not exceed 5% in any of the groups. This suggests that the site of the CB/temporal dispersion in our MMN patients is at a proximal nerve segment (e.g., brachial plexus and nerve root). The possibility that a longer stretch of nerve by cervical root stimulation results in temporal dispersion is negligible because of the absence of such a simple length effect in normal controls and more definitively in ALS with similar CMAP amplitudes. In table 3, postexercise behavior of the CMAPs was shown. The MMN patients had postexercise prolongation of the CMAP onset compared to the ALS group, which is explained by transient, activity-dependent conduction slowing, but its diagnostic yield is limited, given the significant overlap between MMN and controls. The postexercise changes of the CMAP amplitudes and areas were similar among all groups, reflecting the fact that the majority of our MMN patients had temporal dispersion.
Results. Voluntary exercise test and magnetic stimulation for CMAP recordings.
Assessment of parameters in diagnosis of MMN. Because the peaks of each phase of the CMAP were easily identifiable, further assessment of the postexercise changes in the waveforms is shown in figure 1 . A more significant prolongation of the postexercise CMAP durations was observed in the MMN group than in the others, the degree of which varied depending on the parameter. In the MMN group, and the other groups less noticeably, the durations including the segment of positive onset-positive peak showed a more significant increase than the durations without it. Due to the gradual return of the positive phase to baseline, parameters including the end of the positive phase showed less significant change in MMN. Overall, the comparison of the changes in duration between the onset of the negative phase to the positive peak could separate MMN from other groups the most effectively (figure 1, F) (MMN vs ALS: p Ͻ 0.015 and MMN vs controls: p Ͻ 0.005) by defining the upper limit of normal as mean Ϯ 2 SD (i.e., 14.4%). The postexercise prolongation of the CMAP duration was greatest at the immediate MVC period in all groups, but more significantly in the MMN group than the ALS and control groups, and was followed by continuous shortening of the durations in all the groups, even shorter than the baseline durations (more so in the ALS and control groups than the MMN group) ( figure 3A) . Notably, the postexercise prolongation from the negative onset to the negative peak showed no significant increase in MMN compared to other groups (table 3) , largely due to intermittent splitting of the negative waveform in some of the patients (figure 4). In MMN group, the morphology of the positive phase was more stable than the negative phase in postexercise periods. Figure 3B depicts the results of the two serial magnetic fatigue tests in a patient with MMN, recorded before and 2 weeks after completing IVIg treatment. The marked transient prolongation of the CMAP durations seen at baseline significantly improved after IVIg treatment. This appears to be due to less significant ADCB post-therapeutically as the result of improved postexercise safety factor of transmission. On the contrary, no interval change was observed in nerve conduction study parameters (i.e., CMAP amplitude, MCV, and minimal F latency), suggesting that the safety factor of transmission in the resting state is better preserved than the postexercise one in MMN.
Effect of IVIg on MMN.
Discussion. The present study demonstrated that ADCB by magnetic root stimulation (magnetic fatigue test) distinguishes the majority of patients with MMN (six of nine) from patients with ALS. Many of our MMN patients showed neither electrodiagnostic evidence of overt demyelination (e.g., CB, decreased conduction velocity, increased F-wave minimal latency, poorly provoked F waves) by nerve conduction studies nor abnormal antiganglioside titers. In these patients, therefore, the magnetic fatigue test provides greater sensitivity for detecting demyelinating lesions (CB or temporal dispersion). Still, some of the MMN patients did not demonstrate evidence of demyelination by our method, presumably because of inappropriate selection of a tested nerve in MMN patients with upper cervical root involvement. The characteristic diagnostic features in MMN by the magnetic fatigue test are 1) transient postexercise CB or temporal dispersion and 2) transient morphologic change of the waveforms. We employed the same magnetic test protocol in MMN patients with established CB and demonstrated postexercise CB, but not temporal dispersion. 17 The discrepancy is explained by the different degrees of CB in the two studies. A nerve with CB by nerve conduction study is likely to show postexercise CB by a magnetic fatigue test and a nerve with milder degree of demyelination may only show temporal dispersion by a magnetic fatigue test. These findings are explained by transient hyperpolarization of the motor axon membrane and thereby decreased safety factor of transmission. 10 Although MMN has been established as a clear disease entity, the electrodiagnostic finding of CB is not always demonstrable in otherwise typical MMN patients. 11, 16, 29 The previous reports that some MMN patients without electrophysiologic features of overt CB have been found to respond favorably to IVIg have broadened the concept of MMN and therapeutic indication of IVIg. 12 Anti-GM1 and other antiganglioside antibodies are often associated with MMN, and an autoimmune mechanism in MMN has been proposed. However, these abnormalities are not considered to be pathognomonic for diagnosis because of the low sensitivity of the antibody titers in MMN and the reactivity to these antibodies in other neurologic disorders. 30 Among a number of lower motor neuron diseases, clinical improvement by IVIg therapy distinguishes MMN from the others, 7 and until a more sensitive and specific diagnostic test is applicable, the clinical response to IVIg should be used as important supportive evidence of the diagnosis of MMN. At present, the exact prevalence of MMN with no overt CB is unknown; however, it is likely to be underdiagnosed partly because of the lack of a gold standard. The clinical and electrophysiologic features of our MMN patients are similar to those of previous studies.
11 -13,16 Overall, the reasons for the lack of overt CB in otherwise typical MMN may include 1) proximal demyelination as shown in this study, 2) initial demyelination with subsequent axonal degeneration, and 3) pure axonal form of MMN. 13 MMN with axonal involvement is likely to be less responsive to IVIg than its demyelinative counterpart and certainly the magnetic fatigue test may fail to show activity-dependent conduction failure in the axonal form. The normal minimal F latencies of our MMN patients do not preclude demyelinating neuropathy because APB and FDI are innervated by multiple cervical roots. When one of the innervating nerve roots is demyelinated, the minimal F latency generated through the normal nerve root is still normal. In the same condition, however, the CMAP by magnetic stimulation should have temporal dispersion by stimulating the normal and demyelinated nerve roots.
In a normal myelinated nerve fiber, action current through sodium channels at the activated node of Ranvier produces inward ionic current, which subsequently causes outward capacitative current at the next node to be excited, or the driving current. This depolarizes the nodal membrane to the threshold, opening the sodium channels and initiating another cycle of inward ionic current. The ratio of the driving current to the threshold current is called the safety factor of transmission. 31 It is normally Ͼ5, and if it falls below 1, conduction will fail. 10 If the myelin is disrupted, the action current bound for the node dissipates through the internode adjacent to the node of Ranvier (paranode) as a consequence of increased capacitance and decreased resistance. It then takes longer to charge the next node to threshold, prolonging the internodal conduction time. This provides the basis of conduction slowing in a demyelinated nerve fiber. As the demyelination progresses, the current becomes insufficient to depolarize the node to threshold, and the safety factor falls below unity, resulting in conduction failure. In response to increased intracellular Na ϩ concentration due to its influx, a Na ϩ -K ϩ pump transports three Na ϩ ions extracellularly in exchange for two K ϩ ions intracellularly. 19 The activation of the pump thus builds up one net positive ion charge extracellularly, resulting in membrane hyperpolarization. 10, 20, 32 The pump-induced axonal hyperpolarization further compromises the reduced safety factor of transmission at the demyelinating lesion, resulting in ADCB. 10 Because the CMAP amplitudes after fatiguing exercises in normal individuals have been known to be either transiently increased, unchanged, or decreased, 33, 34 the CMAP amplitude is not always a reliable indicator of the property of the axon membrane. To avoid this problem, we assessed the behavior of the CMAP durations extensively in the present study. Concerning the postexercise duration changes, Lagueny et al. 35 have shown by single-fiber EMG that abnormalities of fiber density and jitter exist in MMN, and denervation and reinnervation are the likely explanation. However, our finding of postexercise CB and temporal dispersion by a magnetic fatigue test is less likely to be due to denervation/reinnervation because such findings are lacking by distal electrical stimulation.
In all the tested groups, the CMAP durations showed the largest prolongation immediately after exercise, followed by long-lasting rebound shortening of the durations. These results are in agreement with those of previous studies employing the same duration of voluntary contraction in normal individuals, and the shortening of the CMAP duration has been known to last for at least 1 hour. [36] [37] [38] [39] The possible explanations for this two-phased change in CMAP duration are as follows. First, the rapid postexercise accumulation of metabolites in muscle fibers, especially lactate, causes lowering of the pH of the muscle membrane leading to the slowing of the muscle conduction velocity. It is followed by a longlasting increase in muscle fiber conduction velocity, presumably due to muscle fiber swelling leading to an increase in its diameter and an increase in muscle temperature. 39, 40 Overall, this muscle effect causes postexercise prolongation of the CMAP duration followed by shortening thereafter, affecting equally muscles innervated by normal and demyelinated axons. Second, in a single demyelinated axon, the increased transmission time through the demyeminated lesion caused by the activity-dependent hyperpolarization slows down the CV, thereby causing postexercise delay in the onset of the CMAP and the delay gradually returns to the baseline value. The observed behavior of postexercise changes of CMAP duration and onset is a sum of the effects of the axons with different safety factors of transmission as well as of the muscle fibers ( figure 5 ).
The present study demonstrated that the positive peak of the CMAP showed more significant postexercise prolongation than the negative peak and duration in the majority of the subjects, regardless of the groups, but more significantly in MMN. This finding is in accordance with previous investigations in normal individuals 36, 41 and is because the later portion of the negative phase is more prone to phase cancellation, resulting in less noticeable prolongation of the negative duration than the positive phase ( figure  5C ). The durations including the positive phase, the positive duration, and total duration (see figure 1 for definition) demonstrated no significant prolongation in MMN compared to other groups. We assume that the gradual return of the positive phase to the baseline obscures the prolongation of the end of the positive phase. The transient waveform change during the postexercise period as seen in figure 4 could be explained by different degrees of conduction delay in each nerve fascicule, presumably due to its nonuniform degree of demyelination in MMN. Because of the transient waveform change, neither the negative peak latency or the onset negative peak duration was a reliable diagnostic parameter of MMN (table 3, figure 4) .
Recently, electrical root stimulation was reported to be a sensitive method to detect proximal CB in MMN 42 and demyelinating polyneuropathy. 43, 44 Although the direct comparison of the two methods in detecting proximal demyelination in MMN needs to be explored, the current magnetic fatigue test is unique in detecting mild ADCB. The MVC may alternatively be achieved by high-frequency electrical stimulation, but applying the stimuli in the neck may provoke discomfort and should be performed with caution. In the present study, we did not perform nerve conduction studies of the proximal nerves; thus, the comparison of detecting sensitivity of proximal demyelination requires future study. However, we believe that these methods are rather complementary in assessing a nerve in a resting state by electrical proximal stimulation and dynamic conduction changes by the present method. The magnetic fatigue test and assessment of the parameters are fairly easy, and any laboratory with a magnetic stimulator should be able to perform it. Still, the present method is not intended to precisely localize the site of CB. 
